Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early patient experiences with montelukast orally disintegrating tablets in Japan
jRCT1080223208Completed
- Sponsor
- Merck & Co.
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of montelukast in asthma and allergic rhinitis (AR), sponsored by Merck & Co. Started May 2016; status: completed.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on jRCT1080223208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223208.